Cellgenmedix is the main US distributor of Goodgene, Inc. (www.goodgenekorea.com), a biotech company based in Seoul, Korea with Korean ISO 9001, ISO 14001, and ISO13485 certification for International Standards Organization (ISO), manufacture, and export. We manufacture and sell a number of molecular testing tools including PCR kits and DNA microarrays for the detection of infectious disease, cancer and guiding genomic information-based tailor-made treatment of infectious diseases and cancers.

Good Gene is a South Korean biotechnology company that has led the Korean genetic testing market as well as the DNA microarray market. Their Human Papilloma Virus (HPV) and Sexually transmitted diseases (STD) microarrays were one of the first developed in the world. HPV DNA microarray-related patents were approved in the USA (Patent No: US 7,670,774-B2). The product produced from these patents is the “GG HPV DNA Genoptyping Chip Kit” and the results are outstanding. Prior to this patent, there was no clinically available DNA testing kit that allowed for detection of HPV. Due to this invention, it is now possible to detect early, treat and monitor cervical cancer. GoodGene is a Seoul/South Korea-based biotechnology company with a history of more than 20 years.
GoodGene owns more than 30 patents regarding molecular microbiology and human genetics.
GoodGene owns novel technology in microarray and multiplex nucleic acid amplification.
GoodGene owns a variety of Korean FDA-approved DNA testing kits.
GoodGene owns Quality Management System Certificates for the ISO 9001, ISO 14001, and ISO 13485 for manufacturing of its products.
GoodGene owns Korean FDA-certification for cGMP manufacture and medical device sales.

Based on the basic experimental data and years of experience, Good Gene Inc. is currently launching a new multiplex PCR kit for detection of COVID-19 and its variants, Sexually transmitted diseases (STD) and Human Papilloma Viruses (HPV), as well as cancer radioimmunotherapy. By using DNA and RNA of cancer cells from cancer patients, we developed and patented multiple test kits for the analysis of genetic variation and gene expressions which play a key role in cancer characteristics, drug sensitivity, and toxicity. We also have a hospital in South Korea (“One World Clinic”) specifically for tailor made therapy of incurable diseases such as advanced cancer or stem cell therapy where we treat patients without the restriction of American regulations such as the FDA(publications). We own these multidiciplinary facilities to improve patient care:

Contact: Cellgenmedix, Corp
243 Broadway #9188 Newark, NJ 07104
Tel+1-832-468-6985 Fax: +1 516 953 3453

Manufacturer: Good Gene, InC

28 Digital-ro 30-gil #1111-1112 Guro-gu, Seoul, Republic of Korea (08389)

Fax: +82-2-3409-1330/+1-516 953 3453


(Korean website, old website)

Contact us for product quote or collaborations.